These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 21263240)

  • 21. Papillary hidradenoma of the eyelid margin: clinical and immunohistochemical observations further supporting an apocrine rather than an eccrine origin.
    Jakobiec FA; Rai R; Lefebvre DR
    Surv Ophthalmol; 2014; 59(5):540-7. PubMed ID: 24661803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tubular apocrine adenoma in association with syringocystadenoma papilliferum.
    Aktepe F; Demir Y; Dilek FH
    Dermatol Online J; 2003 Feb; 9(1):7. PubMed ID: 12639465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokeratin 15 expression in apocrine mixed tumors of the skin and other benign neoplasms with apocrine differentiation.
    Misago N; Narisawa Y
    J Dermatol; 2006 Jan; 33(1):2-9. PubMed ID: 16469077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apocrine lesions of the breast: part 1 of a two-part review: benign, atypical and in situ apocrine proliferations of the breast.
    D'Arcy C; Quinn C
    J Clin Pathol; 2019 Jan; 72(1):1-6. PubMed ID: 30409840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Case of clear cell hidradenoma with mucinous metaplasia in the forehead--immunohistochemical analysis of the mucin].
    Ishida M; Kojima F; Kushima R; Kakutani A; Okabe H
    Rinsho Byori; 2006 Aug; 54(8):781-4. PubMed ID: 16989395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myoepithelial cell layer integrity in canine mammary carcinoma.
    Sánchez-Céspedes R; Millán Y; Guil-Luna S; García-Monterde J; Reymundo C; Espinosa de los Monteros A; Martín de las Mulas J
    J Comp Pathol; 2011 Jul; 145(1):25-30. PubMed ID: 21247585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Encapsulated apocrine papillary carcinoma of the breast: case report with clinicopathologic and immunohistochemical study.
    Laforga JB; Gasent JM; Sánchez I
    Diagn Cytopathol; 2011 Apr; 39(4):288-93. PubMed ID: 20734358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.
    Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G
    Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An unusual tumor of the female breast: combined eccrine and apocrine spiradenoma.
    Zawirska B; Cisek T; Markuszewska-Bednarz J
    Patol Pol; 1983; 34(1):125-8. PubMed ID: 6310473
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diagnostic pitfalls in mammary pathology. Case 2. Atypical duct hyperplasia within columnar cell changes with atypia].
    Vincent-Salomon A
    Ann Pathol; 2009 Jun; 29(3):194-8. PubMed ID: 19619825
    [No Abstract]   [Full Text] [Related]  

  • 32. Apocrine adenomyoepithelioma--a rare but distinctive primary sweat gland neoplasm.
    Sabater Marco V
    J Cutan Pathol; 2012 Jul; 39(7):701-6. PubMed ID: 22612240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Breast carcinoma, apocrine variety].
    Guidugli Neto J; Kogos W
    Rev Paul Med; 1990; 108(5):239-40. PubMed ID: 1966399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Squamous cell apocrine hidradenoma.
    Angulo J; Jaqueti G; Kutzner H; Requena L
    J Cutan Pathol; 2007 Oct; 34(10):801-3. PubMed ID: 17880588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fine-needle aspiration cytologic features of four special types of breast cancers: mucinous, medullary, apocrine, and papillary.
    Haji BE; Das DK; Al-Ayadhy B; Pathan SK; George SG; Mallik MK; Abdeen SM
    Diagn Cytopathol; 2007 Jul; 35(7):408-16. PubMed ID: 17580344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.
    Russell TD; Jindal S; Agunbiade S; Gao D; Troxell M; Borges VF; Schedin P
    Am J Pathol; 2015 Nov; 185(11):3076-89. PubMed ID: 26343330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammary cancer antigen recognized by monoclonal antibody B72.3 in apocrine metaplasia of the human breast.
    Castagna M; Nuti M; Squartini F
    Cancer Res; 1987 Feb; 47(3):902-6. PubMed ID: 3542197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications.
    Hilson JB; Schnitt SJ; Collins LC
    Am J Surg Pathol; 2009 Feb; 33(2):227-32. PubMed ID: 18936688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
    Rabban JT; Chen YY
    Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous apocrine mixed tumor with intravascular tumor deposits: a diagnostic pitfall.
    Kazakov DV; Kacerovska D; Skalova A; Zelger B; Schaller J; Shelekhova K; Michal M
    Am J Dermatopathol; 2011 Dec; 33(8):775-9. PubMed ID: 21785330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.